- Home
- QMCO vs BTAI Comparison
QMCO vs BTAI Comparison
Compare QMCO & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMCO
- BTAI
- Stock Information
- Founded
- QMCO 1980
- BTAI 2017
- Country
- QMCO United States
- BTAI United States
- Employees
- QMCO N/A
- BTAI N/A
- Industry
- QMCO Electronic Components
- BTAI Biotechnology: Pharmaceutical Preparations
- Sector
- QMCO Technology
- BTAI Health Care
- Exchange
- QMCO Nasdaq
- BTAI Nasdaq
- Market Cap
- QMCO 13.5M
- BTAI 41.3M
- IPO Year
- QMCO N/A
- BTAI 2018
- Fundamental
- Price
- QMCO $2.51
- BTAI $0.55
- Analyst Decision
- QMCO Hold
- BTAI Strong Buy
- Analyst Count
- QMCO 1
- BTAI 5
- Target Price
- QMCO N/A
- BTAI $5.50
- AVG Volume (30 Days)
- QMCO 79.8K
- BTAI 429.9K
- Earning Date
- QMCO 09-17-2024
- BTAI 08-06-2024
- Dividend Yield
- QMCO N/A
- BTAI N/A
- EPS Growth
- QMCO N/A
- BTAI N/A
- EPS
- QMCO N/A
- BTAI N/A
- Revenue
- QMCO $290,448,000.00
- BTAI $2,403,000.00
- Revenue This Year
- QMCO N/A
- BTAI $251.38
- Revenue Next Year
- QMCO $0.11
- BTAI $112.33
- P/E Ratio
- QMCO N/A
- BTAI N/A
- Revenue Growth
- QMCO N/A
- BTAI 131.50
- 52 Week Low
- QMCO $2.22
- BTAI $0.54
- 52 Week High
- QMCO $18.00
- BTAI $5.62
- Technical
- Relative Strength Index (RSI)
- QMCO 20.74
- BTAI 26.73
- Support Level
- QMCO $3.48
- BTAI $0.59
- Resistance Level
- QMCO $4.60
- BTAI $0.64
- Average True Range (ATR)
- QMCO 0.61
- BTAI 0.05
- MACD
- QMCO -0.10
- BTAI 0.01
- Stochastic Oscillator
- QMCO 6.33
- BTAI 3.37
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.